Health4 hours ago
DATROWAY® Shows Promising Results for Metastatic Breast Cancer Treatment
Positive outcomes from the phase 3 trial TROPION-Breast02 indicate that DATROWAY® (datopotamab deruxtecan) has achieved a statistically significant and clinically meaningful enhancement in overall survival (OS)...
